TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm January 31, 1986
TCL Archive DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards November 5, 1982
TCL Archive In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official June 27, 1980